---
title: "Describe the pharmacology of dexmedetomidine."
entityType: SAQ
exam: PEX
college: ANZCA
year: 2021
sitting: B
question: 4
passRate: 49
EC_expectedDomains:
- "mechanism of action, indications, pharmacokinetics, and pharmacodynamics"
EC_extraCredit:
- "Better answers were able to clearly link the mechanism of action to the pharmacodynamic effects."
- "Credit was given for other relevant, correct material."
EC_errorsCommon:
- "omitting key features, for example those which limit use (e.g. bradycardia), or which are clearly different to other drugs which may be considered in similar clinical contexts (e.g. lack of significant respiratory depression)."
- "significant errors or lack of detail, particularly with respect to: a. mechanism of action, and b. pharmacokinetics."
- "It was less important to provide precise pharmacokinetic data than it was to explain the implications of the pharmacokinetics for clinical practice."
- "Relatively few candidates were aware of administration routes other than intravenous."
---